Rosulive-f

Rosulive-f Tablet contains Rosuvastatin 5mg and Fenofibrate 160mg, a clinically proven combination used to treat mixed dyslipidemia, high LDL cholesterol, and elevated triglyceride levels.

Rosuvastatin helps reduce LDL (bad cholesterol) and increase HDL (good cholesterol), while Fenofibrate effectively lowers high triglycerides, making the combination suitable for comprehensive lipid management.

Rosulive-f belongs to the cardiac, lipid-lowering, and chronic therapy segment, widely prescribed by cardiologists, diabetologists, and general physicians for long-term cardiovascular risk reduction.

For PCD pharma franchise partners, distributors, and exporters, Rosulive-f Tablet offers a strong business opportunity due to its continuous demand in cardiac care. It is available for bulk supply, monopoly-based PCD franchise, third-party manufacturing, institutional distribution, and export.

Indicated for the treatment of high cholesterol, elevated triglycerides, and mixed lipid disorders, especially in patients at risk of cardiovascular complications.

May cause mild side effects like headache, stomach upset, muscle pain, or dizziness. Rarely, serious effects such as liver enzyme changes or muscle damage can occur. Consult your doctor if you experience unexplained muscle pain or weakness.

Use only under medical supervision. Regular monitoring of liver function and lipid levels is recommended. Inform your physician about any pre-existing liver or kidney conditions.

Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.